Cargando…
4483 Activity and Abundance of Mucus-degrading Microbes in Inflammatory Bowel Disease
OBJECTIVES/GOALS: This study seeks to culture and characterize mucus-degrading microbes from the microbiome of inflammatory bowel disease (IBD) patients. METHODS/STUDY POPULATION: Stool will be collected from IBD patients and healthy first-degree relatives, then enriched for mucin-degrading microbes...
Autores principales: | Ostrowski, Matthew, Martens, Eric C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823595/ http://dx.doi.org/10.1017/cts.2020.288 |
Ejemplares similares
-
2325: Steroid therapy limits stem cell activation required to enact mucosal healing in inflammatory bowel disease
por: Brady Lynch, Evan, et al.
Publicado: (2018) -
95332 Intestinal inflammation and altered gut microbiota associated with inflammatory bowel disease render mice susceptible to Clostridioides difficile colonization and infection
por: Barron, Lisa Abernathy-Closedeline R., et al.
Publicado: (2021) -
2097: Aging-associated increases in platelet granzyme A regulate pro-inflammatory gene synthesis by monocytes
por: Thomas Rondina, Matthew, et al.
Publicado: (2018) -
2078: NGF and TNF-α contribute to oral cancer pain by regulating pro-inflammatory cytokines
por: Ye, Yi, et al.
Publicado: (2018) -
4119 Cholecystokinin (CCK) Receptor Antagonist Reverses Nonalcoholic Steatohepatitis (NASH) by Reducing Hepatic Macrophages and Inflammatory Cytokines
por: Gay, Martha, et al.
Publicado: (2020)